Mike Matson

Q: What is Mike Matson's success rate?

Mike Matson currently has a success rate of 89.3859863581988.

Q: What is the average return of Mike Matson's calls?

Their stock ratings have generated an average return of 7.513971908817697.

Needham | Healthcare

Mike Matson is an analyst from Needham specializing in the Healthcare sector. Ranked #1953 out of 4684 analysts, they have issued 82 stock ratings with a success rate of 89.39% and an average return of 7.51%.

Mike Matson has a well-established track record, with 82 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 89.39% and an average return of 7.51%, underscoring their expertise and ability to identify winning opportunities for investors.

#1953

Out of 4684

Total Ratings

+89.39%

Success Rate

+7.51%

Average Return

Recent Ratings Analysis

MDT

Buy

Jun 03, 2026

Target

$101.00

Current

$80.20

Performance

2.89%

Mike Matson rated MDT as Buy on Jun 03, 2026, setting a price target of 101. Shares have remained stable near 80.2, leaving the 101 target still in play.

VCYT

Buy

Jun 01, 2026

Target

$57.00

Current

$47.33

Performance

-1.76%

On Jun 01, 2026, VCYT was given a Buy rating by Mike Matson, with a target price of 57. The stock traded sideways with a -1.76% move, keeping the bullish thesis unresolved.

ICUI

Buy

May 27, 2026

Target

$165.00

Current

$142.20

Performance

2.79%

ICUI received a Buy rating from Mike Matson on May 27, 2026, aiming for 165. Price action was muted, as shares hovered around 142.2 despite the bullish outlook.

BSX

Buy

May 18, 2026

Target

$77.00

Current

$46.91

Performance

-16.11%

On May 18, 2026, Mike Matson published a Buy outlook on BSX, with a target of 77. Market action contradicted the Buy thesis, as shares slipped to 46.91.

AORT

Buy

May 08, 2026

Target

$44.00

Current

$20.10

Performance

-20.90%

Mike Matson on May 08, 2026 assigned AORT a Buy rating, with a price target of 44. The call has struggled to gain traction, with shares losing 20.90%.

TMDX

Buy

May 06, 2026

Target

$142.00

Current

$72.91

Performance

-0.01%

On May 06, 2026, Mike Matson reaffirmed TMDX with a Buy rating, targeting 142. Market indecision has kept the 142 target in a holding pattern.

MMSI

Buy

May 01, 2026

Target

$90.00

Current

$66.53

Performance

—

MMSI was rated Buy by Mike Matson on May 01, 2026, with a price objective of 90. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

SYK

Buy

May 01, 2026

Target

$418.00

Current

$312.20

Performance

—

On May 01, 2026, Mike Matson initiated coverage on SYK with a Buy rating and target of 418. Neutral price movement of % leaves room for interpretation.

LUCD

Buy

Mar 26, 2026

Target

$3.00

Current

$0.96

Performance

—

Mike Matson issued a Buy recommendation for LUCD on Mar 26, 2026, price target set at 3. The target of 3 remains in play, though confirmation will depend on future moves.

PSNL

Buy

Feb 27, 2026

Target

$12.00

Current

$9.59

Performance

5.85%

On Feb 27, 2026, PSNL was evaluated by Mike Matson, who gave a Buy rating and target of 12. This case illustrates how a timely bullish rating can translate into tangible gains of 5.85%.

KIDS

Buy

Feb 27, 2026

Target

$30.00

Current

$17.82

Performance

-7.04%

Mike Matson rated KIDS as Buy on Feb 27, 2026, setting a price target of 30. The stock has underperformed, dropping 7.04% despite the bullish target of 30.

ENOV

Buy

Feb 26, 2026

Target

$52.00

Current

$21.80

Performance

-14.24%

On Feb 26, 2026, ENOV was given a Buy rating by Mike Matson, with a target price of 52. Despite the Buy call, shares fell from 21.8 to 21.8, challenging the optimistic stance.

TFX

Buy

Feb 26, 2026

Target

$147.00

Current

$130.48

Performance

9.63%

TFX received a Buy rating from Mike Matson on Feb 26, 2026, aiming for 147. Momentum has favored the Buy call, with shares climbing from 130.48 to 130.48, rewarding those who trusted the recommendation.

LIVN

Buy

Feb 25, 2026

Target

$81.00

Current

$79.39

Performance

12.95%

On Feb 25, 2026, Mike Matson published a Buy outlook on LIVN, with a target of 81. Shares gained 12.95%, underscoring the accuracy of the bullish outlook toward 81.

ESTA

Buy

Feb 24, 2026

Target

$86.00

Current

$82.14

Performance

3.10%

Mike Matson on Feb 24, 2026 assigned ESTA a Buy rating, with a price target of 86. The recommendation remains pending validation as shares consolidate around 82.14.

NEO

Buy

Feb 17, 2026

Target

$15.00

Current

$11.15

Performance

-2.53%

On Feb 17, 2026, Mike Matson reaffirmed NEO with a Buy rating, targeting 15. Market indecision has kept the 15 target in a holding pattern.

ATRC

Buy

Feb 12, 2026

Target

$45.00

Current

$28.79

Performance

-9.47%

ATRC was rated Buy by Mike Matson on Feb 12, 2026, with a price objective of 45. This case shows how bullish projections can fail, with the stock now below 28.79.

ZBH

Hold

Feb 10, 2026

Target

—

Current

$88.57

Performance

-3.10%

On Feb 10, 2026, Mike Matson initiated coverage on ZBH with a Hold rating and target of null. The stock’s lack of movement around 88.57 aligned with a cautious approach.

CNMD

Hold

Jan 29, 2026

Target

—

Current

$34.77

Performance

-6.81%

Mike Matson issued a Hold recommendation for CNMD on Jan 29, 2026, price target set at null. Market action validated the conservative Hold outlook with shares at 34.77.

PEN

Hold

Jan 16, 2026

Target

—

Current

$318.71

Performance

-9.14%

On Jan 16, 2026, PEN was evaluated by Mike Matson, who gave a Hold rating and target of null. The Hold call avoided chasing into subsequent weakness of 9.14%.

HAE

Hold

Dec 15, 2025

Target

—

Current

$78.20

Performance

-2.74%

Mike Matson rated HAE as Hold on Dec 15, 2025, setting a price target of null. The Hold stance appears justified, as shares hovered around 78.2 with a -2.74% move.

IMDX

Buy

Nov 11, 2025

Target

$9.00

Current

$5.61

Performance

-25.50%

On Nov 11, 2025, IMDX was given a Buy rating by Mike Matson, with a target price of 9. Despite the Buy call, shares fell from 5.61 to 5.61, challenging the optimistic stance.

HOLX

Hold

Oct 21, 2025

Target

—

Current

$76.01

Performance

2.74%

HOLX received a Hold rating from Mike Matson on Oct 21, 2025, aiming for null. Shares remained flat at 76.01, aligning with the neutral rating.

INMD

Hold

Oct 10, 2025

Target

—

Current

$13.45

Performance

-11.92%

On Oct 10, 2025, Mike Matson published a Hold outlook on INMD, with a target of null. Weakness in the stock, now at 13.45, supported the conservative rating.

MASI

Hold

Apr 10, 2025

Target

—

Current

$179.95

Performance

18.79%

Mike Matson on Apr 10, 2025 assigned MASI a Hold rating, with a price target of null. Shares outperformed expectations, climbing 18.79% despite the neutral view.

INGN

Hold

Apr 09, 2025

Target

—

Current

$6.40

Performance

-9.09%

On Apr 09, 2025, Mike Matson reaffirmed INGN with a Hold rating, targeting null. The Hold stance reflected market caution that was later justified.

OCX

Buy

Apr 08, 2025

Target

$4.25

Current

$3.20

Performance

16.36%

OCX was rated Buy by Mike Matson on Apr 08, 2025, with a price objective of 4.25. A bullish response from the market helped close the gap of 1.05 to the target.

STE

Hold

Apr 07, 2025

Target

—

Current

$207.56

Performance

-2.44%

On Apr 07, 2025, Mike Matson initiated coverage on STE with a Hold rating and target of null. The stock’s lack of movement around 207.56 aligned with a cautious approach.

RMD

Hold

Jan 31, 2025

Target

—

Current

$194.78

Performance

-17.53%

Mike Matson issued a Hold recommendation for RMD on Jan 31, 2025, price target set at null. Market action validated the conservative Hold outlook with shares at 194.78.

SRDX

Hold

Jan 30, 2025

Target

—

Current

$42.98

Performance

21.14%

On Jan 30, 2025, SRDX was evaluated by Mike Matson, who gave a Hold rating and target of null. Investors who stayed in despite the Hold saw upside of 21.14%.

FNA

Hold

Jan 29, 2025

Target

$13.00

Current

$13.09

Performance

0.77%

Mike Matson rated FNA as Hold on Jan 29, 2025, setting a price target of 13. The Hold stance appears justified, as shares hovered around 13.09 with a 0.77% move.

NARI

Hold

Oct 09, 2024

Target

—

Current

$79.97

Performance

91.82%

On Oct 09, 2024, NARI was given a Hold rating by Mike Matson, with a target price of null. The stock rallied from 79.97 to 79.97 after the Hold rating, surprising to the upside.

AXNX

Hold

May 06, 2024

Target

—

Current

$70.98

Performance

5.02%

AXNX received a Hold rating from Mike Matson on May 06, 2024, aiming for null. Investors saw gains of 5.02% that the cautious stance didn’t fully capture.

Frequency Asked Questions

Who is Mike Matson?

Mike Matson is an analyst from Needham specializing in the Healthcare sector.

What is Mike Matson's success rate?

Mike Matson currently has a success rate of +89.39%.

How many ratings has Mike Matson issued?

Mike Matson has issued 82 stock ratings so far.

What is the average return of Mike Matson's calls?

Their stock ratings have generated an average return of +7.51%.

What is Mike Matson's ranking?

Mike Matson is ranked #1953 out of 4684 analysts.

What types of ratings does Mike Matson give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Mike Matson?

You can follow Mike Matson by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Mike Matson?

Their latest rating was a Buy on MDT issued on 2026-06-03.